Source: Health Products Regulatory Authority (ZA) Publisher: Ruby Pharmaceuticals (PTY) LTD, P.O. Box 431, Pinetown 3600
RUBILIM CR 200 mg (Prolonged release tablets).
RUBILIM CR 300 mg (Prolonged release tablets).
RUBILIM CR 500 mg (Prolonged release tablets).
| Pharmaceutical Form |
|---|
|
RUBILIM CR 200 mg is a film coated, oblonged shaped and violet coloured prolonged release tablet. RUBILIM CR 300 mg is a film coated, oblonged shaped and blue coloured prolonged release tablet. RUBILIM CR 500 mg is a film coated, oblonged shaped and violet coloured prolonged release tablet. |
RUBILIM CR 200: each prolonged release tablet contains 133,2 mg sodium valproate and 58,0 mg valproic acid equivalent to 200 mg sodium valproate.
RUBILIM CR 300: each prolonged release tablet contains 199,8 mg sodium valproate and 87,0 mg valproic acid equivalent to 300 mg Sodium Valproate.
RUBILIM CR 500: each prolonged release tablet contains 333,0 mg sodium valproate and 145,0 mg valproic acid equivalent to 500 mg sodium valproate.
Sugar free.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Valproic acid |
Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. |
| List of Excipients |
|---|
|
Tablet core: Hypromellose Coating: Opadry OY-S-6705 violet |
RUBILIM CR is packed in cold form ALU-ALU blister packs in cartons of 56, 60, 100 or 120 or 140 tablets.
Not all pack sizes may be marketed.
Ruby Pharmaceuticals (PTY) LTD, P.O. Box 431, Pinetown 3600
6 April 2022
| Drug | Countries | |
|---|---|---|
| RUBILIM | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
